HKEX Stock Code: 01093English|繁體|简体
Home > Investor Relations > Announcements & Notices
Announcements & Notices
Dec
27
PROPOSED SPIN-OFF AND SEPARATE LISTING OF CSPC XNW GROUP ON THE SHENZHEN STOCK EXCHANGE
Dec
12
List of Directors and their Role and Function
Dec
12
APPOINTMENT OF EXECUTIVE DIRECTOR
Dec
05
List of Directors and their Role and Function
Dec
05
RESIGNATION OF DIRECTOR
Nov
17
CHANGE OF SHAREHOLDINGS OF SUBSTANTIAL SHAREHOLDER
Nov
15
UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2017
Nov
06
VOLUNTARY ANNOUNCEMENT - THE GROUP'S "HA121-28" AND "ALPROSTADIL LIPOSOME INJECTION" WERE GRANTED CLINICAL TRIAL APPROVALS
Nov
03
DATE OF BOARD MEETING
Oct
20
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Oct
13
PLACING OF NEW SHARES UNDER GENERAL MANDATE AND RESUMPTION OF TRADING
Oct
12
TRADING HALT
Oct
11
CONNECTED TRANSACTION - ACQUISITION OF 1.31% EQUITY INTEREST IN CSPC INNOVATION PHARMACEUTICAL CO., LTD.
Sep
27
VOLUNTARY ANNOUNCEMENT - THE GROUP'S MALIGNANT TUMOUR TREATMENT DRUG "MITOXANTRONE HYDROCHLORIDE LIPOSOME' WAS GRANTED ORPHAN-DRUG DESIGNATION BY THE U.S. FDA
Aug
29
CONTINUING CONNECTED TRANSACTIONS - RENEWAL OF STEAM SUPPLY AGREEMENT
Aug
22
2017 INTERIM RESULTS ANNOUNCEMENT
Aug
10
DATE OF BOARD MEETING
Jun
25
DISCLOSEABLE TRANSACTION-LICENSE AGREEMENTS RELATING TO PATENT AND TECHNOLOGY RIGHTS
May
29
CONNECTED TRANSACTION - ACQUISITION OF LIMITED PARTNERSHIP INTEREST IN A FUND
May
25
ARTICLES OF ASSOCIATION
May
25
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
May
25
APPOINTMENT OF VICE-CHAIRMAN AND ROTATING CHIEF EXECUTIVE OFFICER
May
25
RETIREMENT OF EXECUTIVE DIRECTOR
May
25
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2017
May
25
UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2017
May
15
DATE OF BOARD MEETING
May
09
CONNECTED TRANSACTION-ACQUISITION OF THE ENTIRE EQUITY INTEREST IN CSPC DOPHEN CORPORATION
Apr
19
NOTICE OF ANNUAL GENERAL MEETING
Apr
18
INSIDE INFORMATION - PROPOSED SPIN-OFF AND LISTING OF CSPC XNW ON A STOCK EXCHANGE IN THE PRC
Apr
10
PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION
Mar
20
ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016
Mar
08
DATE OF BOARD MEETING
Mar
03
CONNECTED TRANSACTION - ACQUISITION OF THE ENTIRE EQUITY INTEREST IN HEBEI SHIWEI PHARMACEUTICAL TRADING CO., LTD.

Please download the latest "Acrobat Reader" to view the PDF.

© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.
Disclaimer